Clene Unveils Promising Data on CNM-Au8 for Rett Syndrome Treatment
Clene presents new preliminary data on CNM-Au8 for Rett Syndrome treatment, showing promising potential for addressing this severe pediatric neurological disorder.
This news matters because it represents a potential breakthrough in the treatment of Rett Syndrome, a severe and rare pediatric neurological disorder. The preliminary data on CNM-Au8 presents hope for improved treatment options, which could positively impact the lives of individuals affected by this condition.
